Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors
This study is currently recruiting participants.
Verified February 2013 by Prism Pharma Co., Ltd.
Sponsor:
Prism Pharma Co., Ltd.
Collaborator:
inVentiv Health Clinical
Information provided by (Responsible Party):
Prism Pharma Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01302405
First received: February 18, 2011
Last updated: February 19, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2014 |
| Estimated Primary Completion Date: | February 2014 (Final data collection date for primary outcome measure) |